CONVENIOS

Agreement

MANEJO DEL PACIENTE CON ESCLEROSIS MÚLTIPLE REFRACTARIO AL TRATAMIENTO INMUNOMODULADOR DE PRIMERA LÍNEA.

Funders: LABORATORIOS ALMIRALL SA, BAYER HISPANIA SLU, TEVA PHARMA SLU

Duration: from 16 September 2013 to 05 September 2016 (36 months) Finished

17,000.00 EUR

Of National scope.

In collaboration with other entities.

Call: (FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID)

Leader